These findings underscore the multifaceted role of ALKBH5 in both regulating tumor cell behavior and shaping the immune landscape within the liver cancer microenvironment, positioning it as a potential therapeutic target in liver cancer management (56). This evidence concerns the gene ALKBH5 and neoplasm.